Jin Yang Pharmaceutical Co. Ltd (007370) — Cash Flow-to-Debt Ratio
Jin Yang Pharmaceutical Co. Ltd (007370) has a Cash Flow-to-Debt Ratio of 0.04x as of March 2026, meaning its operating cash flow of ₩4.53 Billion could theoretically repay 0% of its total liabilities (₩111.51 Billion) in one year. Explore Jin Yang Pharmaceutical Co. Ltd (007370) investment intensity to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Jin Yang Pharmaceutical Co. Ltd Cash Flow-to-Debt Ratio (2014–2025)
Historical debt coverage capacity for Jin Yang Pharmaceutical Co. Ltd across 12 annual periods. Also explore Jin Yang Pharmaceutical Co. Ltd balance sheet assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Jin Yang Pharmaceutical Co. Ltd (2014–2025)
Year-by-year debt coverage analysis for Jin Yang Pharmaceutical Co. Ltd. For market capitalisation and broader financial context, see Jin Yang Pharmaceutical Co. Ltd stock valuation.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.01x | ₩1.46 Billion | ₩107.95 Billion | ▼ -88.6% |
| 2024 | 0.12x | ₩12.79 Billion | ₩107.70 Billion | ▼ -57.8% |
| 2023 | 0.28x | ₩8.53 Billion | ₩30.32 Billion | ▲ +39.3% |
| 2022 | 0.20x | ₩7.45 Billion | ₩36.87 Billion | ▲ +240.2% |
| 2021 | 0.06x | ₩1.97 Billion | ₩33.18 Billion | ▼ -79.3% |
| 2020 | 0.29x | ₩6.24 Billion | ₩21.77 Billion | ▼ -2.1% |
| 2019 | 0.29x | ₩7.21 Billion | ₩24.61 Billion | ▲ +675.1% |
| 2018 | 0.04x | ₩1.06 Billion | ₩28.01 Billion | ▲ +220.5% |
| 2017 | -0.03x | ₩-987.16 Million | ₩31.47 Billion | ▼ -6337.5% |
| 2016 | 0.00x | ₩-13.47 Million | ₩27.64 Billion | ▲ +99.5% |
| 2015 | -0.10x | ₩-2.76 Billion | ₩27.72 Billion | ▲ +50.9% |
| 2014 | -0.20x | ₩-3.08 Billion | ₩15.20 Billion | — |